BOLT BIOTHERAPEUTICS
0,6513
07-ноября-24 15:59:03
15 мин. задержка
Акции
+0,0037
+0,57%
Сегодняшний диапазон
0,6406 - 0,6700
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
03 авг 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023
31 июл 2023 17:27:56 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
11 май 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
26 апр 2023 10:00:00 Источник Nasdaq GlobeNewswire
-
29 мар 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
29 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
14 мар 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Cowen 43rd Annual Healthcare Conference
28 фев 2023 08:00:05 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at February Investor Conferences
01 фев 2023 08:00:02 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Appoints Laura Berner to Board of Directors
14 дек 2022 16:43:15 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
10 ноя 2022 16:05:02 Источник Nasdaq GlobeNewswire
-
07 ноя 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Stifel 2022 Healthcare Conference
01 ноя 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
31 авг 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
10 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
27 май 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights
12 май 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Bolt Biotherapeutics to Present at 21st Annual Needham Healthcare Conference
07 апр 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
30 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire